Tarceva (erlotinib HCl)

DRUG4 trials

Sponsors

Genentech, Inc.

Conditions

Lung CancerMetastasesNeoplasm Recurrence, LocalNon-Small-Cell Lung CarcinomaNon-small-cell Lung CarcinomaRenal Cell Carcinoma

Phase 2

A Study Evaluating Tarceva in Combination With Avastin Versus Avastin Alone in Treating Metastatic Renal Cell Carcinoma

CompletedNCT00081614

Genentech, Inc.Metastases, Renal Cell Carcinoma

Start: 2004-03-31End: 2005-07-31Target: 100Updated: 2014-05-16

A Study to Evaluate Bevacizumab and Chemotherapy or Tarceva in Treating Recurrent or Refractory NSCLC (Non-Small Cell Lung Cancer)

CompletedNCT00095225

Genentech, Inc.Neoplasm Recurrence, Local, Non-Small-Cell Lung Carcinoma

Start: 2004-07-31End: 2006-11-30Updated: 2008-01-29

Phase 3

A Study With Tarceva and Chemotherapy vs. Chemotherapy Alone in Patients With Advanced Lung Cancer

CompletedNCT00047736

Genentech, Inc.Lung Cancer

Start: 2001-07-31End: 2003-07-31Updated: 2013-06-21

A Study to Evaluate Tarceva in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)

CompletedNCT00091663

Genentech, Inc.Lung Cancer, Non-small-cell Lung Carcinoma

Start: 2004-08-31End: 2005-08-31Target: 5000Updated: 2014-03-04